(±)-2-(O-CHLOROPHENYL)-2-(METHYLAMINO)CYCLOHEXANONE
Hemispatial Neglect
Imperial College LondonSmall moleculePhase 2Dormant
B
57/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 42/ 100
- Competitive Position
- 95/ 100
Competitive context
0 Active assets in the Hemispatial Neglect cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
NEPENTHE Christian Medical College and Hospital, Ludhiana, India | Phase 3 | BB |
DEXKETOPROFEN Christian Medical College and Hospital, Ludhiana, India | Phase 3 | BB |
METAMIZOLE Christian Medical College and Hospital, Ludhiana, India | Phase 3 | BB |
Rotigotine University College, London | Phase 2 | B |
Guanfacine Imperial College London | Phase 2 | B |
Same molecule, other indications
(±)-2-(O-CHLOROPHENYL)-2-(METHYLAMINO)CYCLOHEXANONE is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →